Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510458 · ClinicalTrials.gov registry record · NA
LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
A NA study, sponsored by Stryker Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT00510458 is a NA study that has completed, run by Stryker Orthopaedics. The registered enrollment target is 89 participants.
The verdict
NCT00510458, a NA study, has completed, sponsored by Stryker Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment). The large size femoral heads will be used with the Trident® X3® polyethylene (plastic) inserts and will be compared with a historical control. Study Hypothesis: The linear wear rate for hips implanted with the LFIT™ Anatomic CoCr Femoral Head is no worse than 0.08 mm wear per year at 5 years post-surgery.
Interventions
- DEVICE LFIT™ Femoral Heads With X3® Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-04 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00510458
The ClinicalTrials.gov registry entry for NCT00510458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LFIT™ Femoral Heads With X3® Insert is the first listed.
NCT00510458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00510458 about?
NCT00510458 is a clinical study titled "LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study". Total hip replacement surgery is considered to be a very successful surgical procedure for the treatment of degenerative joint disease. The purpose of the study is to evaluate a large size (36mm, 40mm or 44mm) femoral (hip) head called the LFIT™ Anatomic CoCr Femoral Head (Low Friction Ion Treatment...
What is the current status of trial NCT00510458?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2007-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT00510458?
The interventions under investigation include: LFIT™ Femoral Heads With X3® Insert (DEVICE).
Who is sponsoring clinical trial NCT00510458?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.